- Home
- XGN vs AXR Comparison
XGN vs AXR Comparison
Compare XGN & AXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XGN
- AXR
- Stock Information
- Founded
- XGN 2002
- AXR 1961
- Country
- XGN United States
- AXR United States
- Employees
- XGN N/A
- AXR N/A
- Industry
- XGN Medical Specialities
- AXR Homebuilding
- Sector
- XGN Health Care
- AXR Real Estate
- Exchange
- XGN Nasdaq
- AXR Nasdaq
- Market Cap
- XGN 138.3M
- AXR 114.8M
- IPO Year
- XGN 2019
- AXR N/A
- Fundamental
- Price
- XGN $10.10
- AXR $22.05
- Analyst Decision
- XGN Strong Buy
- AXR
- Analyst Count
- XGN 4
- AXR 0
- Target Price
- XGN $11.75
- AXR N/A
- AVG Volume (30 Days)
- XGN 374.8K
- AXR 9.4K
- Earning Date
- XGN 07-29-2025
- AXR 09-12-2025
- Dividend Yield
- XGN N/A
- AXR N/A
- EPS Growth
- XGN N/A
- AXR 89.60
- EPS
- XGN N/A
- AXR 2.37
- Revenue
- XGN $58,862,000.00
- AXR $49,694,000.00
- Revenue This Year
- XGN $19.68
- AXR $124,160.48
- Revenue Next Year
- XGN $13.68
- AXR $8.16
- P/E Ratio
- XGN N/A
- AXR $9.51
- Revenue Growth
- XGN 3.89
- AXR N/A
- 52 Week Low
- XGN $2.38
- AXR $17.60
- 52 Week High
- XGN $10.29
- AXR $39.68
- Technical
- Relative Strength Index (RSI)
- XGN 77.40
- AXR 48.35
- Support Level
- XGN $9.39
- AXR $21.45
- Resistance Level
- XGN $9.90
- AXR $22.52
- Average True Range (ATR)
- XGN 0.44
- AXR 0.51
- MACD
- XGN 0.03
- AXR -0.02
- Stochastic Oscillator
- XGN 88.52
- AXR 29.85
About XGN Exagen Inc.
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.
About AXR AMREP Corporation
Amrep Corp through its subsidiaries is engaged in the Real estate business. Its activities include land sales and lease activities, which involve obtaining approvals and selling both developed and undeveloped lots to homebuilders, commercial users, and others, as well as investments in commercial and investment properties. The Company accounts for land sales, home sales, and other revenues. Its operating segments include Land development and Homebuilding. The firm generates a majority of its revenue from the Land development segment. Geographically, all the activities are carried out throughout the United States.